MindWalk Holdings (HYFT) Capital Expenditures (QoQ) (2023 - 2026)
Powered by 
Analysis
MindWalk Holdings (HYFT) Capital Expenditures (QoQ) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | MindWalk Holdings | 62.15 Mn | 53.87 Mn | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 64.08% |
| Jan 31, 2026 | 58.13% |
| Oct 31, 2025 | 74.01% |
| Jul 31, 2025 | 18.65% |
| Apr 30, 2025 | -219.76% |
| Jan 31, 2025 | -65.75% |
| Oct 31, 2024 | 75.22% |
| Jul 31, 2024 | 76.89% |
| Apr 30, 2024 | -781.00% |
| Jan 31, 2024 | 155.35% |
| Oct 31, 2023 | -116.42% |
| Jul 31, 2023 | 70.16% |
| Apr 30, 2023 | 74.71% |